See today's BioWorld
To read the full story, subscribe or sign in.

As midyear looms, hinges squeaky but IPO window still open

June 26, 2015
By Marie Powers
Catabasis Pharmaceuticals Inc. made a respectable debut on Nasdaq after pricing its IPO, generating $60 million from the sale of 5 million common shares at $12 apiece.
BioWorld